Overview
Investment Type
Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 7, 2012 | 4s3 Bioscience Closes $20M Series A Financing | 4s3 Bioscience, Inc. (4s3), a Boston-area biotherapeutics company focused on developing genetic disease therapies for orphan neuromuscular disorders, has closed a $20m Series A financing with KLP Enterprises, LLC. The company intends to use... |
| Dec 27, 2011 | Provenance Biopharmaceuticals Closes $8M Financing with Alopexx Enterprises | Provenance Biopharmaceuticals Corp., a Waltham, MA-based clinical-stage biotechnology company focused on developing novel therapeutics for cancer and other serious, life-threatening diseases, has closed an $8m financing with Alopexx Enterpr... |
Reviews 0
FAQ about Alopexx Enterprises
How many startups has Alopexx Enterprises invested in?
Alopexx Enterprises has 1 portfolio company on Parsers VC.
What has the press written about Alopexx Enterprises?
Parsers VC has collected 3 articles mentioning Alopexx Enterprises, among them “4s3 Bioscience Closes $20M Series A Financing” (Mar 7, 2012) and “Provenance Biopharmaceuticals Closes $8M Financing with Alopexx Enterprises” (Dec 27, 2011).
Is Alopexx Enterprises still active?
Yes, Alopexx Enterprises is active; its latest activity on Parsers VC dates from Sep 11, 2024.